| Ytd | -11.23% | |
| 1y | 2.60% |
| Open | 415.40 | Prev Close | 417.82 | Low | 414.16 | High | 419.81 | Mkt Cap | 89.73B |
| Vol | 1.31M | Avg Vol | 1.58M | EPS | 29.59 | P/E | 14.01 | Forward P/E | 12.91 |
| Beta | 1.11 | Short Ratio | 3.86 | Inst. Own | 78.93% | Dividend | 3.12 | Div Yield | 0.75 |
| Ex Div Date | 09-16 | Earning | 10-23 | 50-d Avg | 400.27 | 200-d Avg | 453.57 | 1yr Est | 451.48 |
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially suppo
On August 25, 2026, we conducted a DCF analysis for HCA Healthcare Inc (HCA), a company that has sho
Bank of Nova Scotia acquired a new position in shares of HCA Healthcare, Inc. (NYSE: HCA) in the sec
B. Metzler seel. Sohn and Co. AG bought a new position in HCA Healthcare, Inc. (NYSE: HCA) during th
Advisors Capital Management LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) i
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the f
JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers th
BlackRock Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the second quar
On August 18, 2026, we conducted a discounted cash flow (DCF) analysis for HCA Healthcare Inc (HCA)
Assenagon Asset Management S.A. lessened its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 81.0% d
Deane Retirement Strategies Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA)
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schl
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Fortinet, Inc. (NASDAQ:FTNT) is good and he l
CNBC's Jim Cramer offers his takes on various companies, including CME Group, Alcoa, Rocket Lab,
If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Braga
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
The law firm of [url="]Kirby McInerney LLP[/url] reminds investors of its investigation on behalf of
NEW YORK--(BUSINESS WIRE)---- $HCA #classaction--The law firm of Kirby McInerney LLP reminds investo
Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and ra
NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the pri
U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Leadi
Multiple members of Congress disclose buying SpaceX stock, even some who aren't big fans of Elon
UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target
HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in
Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight an
HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and mainta
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowe
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers th
Crude fell about 4% on renewed US-Iran talk hopes, easing yields and fueling a broad rally in real e
Most investors know which stocks they’d like to own. The harder part is deciding when, and at what p
HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift an
HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $28.70-$30.50 to $28.70-$30.50 vs $2
HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.59 per share which beat the analyst cons
Companies Reporting Before The Bell • Charter Communications (NASDAQ:CHTR) is likely to report quart
Market sentiment declines, Nasdaq falls 2%, Trump warns Iran, Tesla and T-Mobile stock drops, while
US stock futures mixed, focus on companies like American Express, Deckers, Verizon, Edwards Lifescie
ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers th
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers
Intuitive Surgical shares slid to a fresh 52-week low Tuesday, caught in a broader pullback across m
HCA Healthcare's preliminary Q2 results showed higher revenue and EPS despite a $400 million hit
HCA Healthcare (NYSE:HCA) Narrows FY2026 sales outlook from $76.500 billion-$80.000 billion to $77.0